Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.
2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.
Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.
Magnolia Medical Technologies is a device development company that focuses on improving the accuracy of diagnostic blood culture tests.
Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.
Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.
Basking Biosciences is to commercialize technology developed at Duke and Ohio State Universities.
Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.
Alesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic.
Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.
Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.
Ottimo Pharma develops innovative cancer therapies using PD1-VEGFR2 antibodies.
Yarrow is developing a first-in-class antibody targeting TSHR for the treatment of Graves’ disease and thyroid eye disease.
AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.
Belite Bio is a clinical stage biopharmaceutical drug development company.
Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.
Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.
Mirador Therapeutics develops precision medicines for immune-mediated diseases.
Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.
Biomea Fusion is a precision oncology company developing novel small molecules that target aggressive forms of cancer.
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
RTW Investments has invested in 107 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RTW Investments's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Life Science. The firm invests across 14 different industry categories.
Among tracked funding rounds, Dianthus Therapeutics received $719.0M in a Post-IPO Equity round. RTW Investments's total known invested capital is $11.5B.
RTW Investments's average investment size is $139.0M across its portfolio of 107 companies.
Recent RTW Investments portfolio additions include Dianthus Therapeutics, 2seventy bio, Roivant Sciences, Magnolia Medical Technologies, Kailera Therapeutics. These companies were founded in 2020 or later.